What is the impact of craniopharyngioma on the sella turcica and surrounding structures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Craniopharyngioma and Sella Turcica Anatomy

Anatomic Location and Relationship

Craniopharyngiomas are benign embryogenic tumors that primarily arise in the sellar and suprasellar regions, with the sella turcica serving as the anatomic foundation from which these tumors originate or through which they extend. 1, 2

Primary Tumor Origins

  • Craniopharyngiomas arise from epithelial remnants of the craniopharyngeal duct or Rathke's pouch (adamantinomatous type) or from metaplastic squamous epithelial cells that are remnants of the stomadeum (squamous papillary type) 1
  • These tumors characteristically occupy the sellar, suprasellar, and parasellar regions of the central nervous system 3, 1
  • The sella turcica itself can be directly involved, with tumor extension causing sellar expansion and bony remodeling 4

Patterns of Sellar Involvement

  • Suprasellar extension is the most common pattern, with tumors growing upward from the sella to compress the optic chiasm and hypothalamus 5, 2
  • Infrasellar craniopharyngiomas are extremely rare, with only 35 cases reported in the literature, where tumors originate from the sphenoid bone with extension into the sella turcica 4
  • Nasopharyngeal craniopharyngiomas can involve the sella turcica secondarily, though this represents an unusual presentation 6

Impact on Surrounding Structures

Bony Changes to the Sella Turcica

  • CT imaging demonstrates that craniopharyngiomas can cause bone-destructive lesions of the skull base affecting the sella turcica 5
  • Larger tumors may cause sellar remodeling including sellar enlargement, bony erosion, suprasellar extension, invasion into the clivus, or sphenoid sinus involvement 5
  • The characteristic location and bony changes help distinguish craniopharyngiomas from other sellar masses 5

Compression of Neurovascular Structures

  • Visual disturbances occur from compression of the optic chiasm by suprasellar tumor extension, representing one of the most common presenting symptoms 3, 1
  • Displacement or encasement of vessels in the suprasellar region can occur, requiring MRA for surgical planning 5
  • Cavernous sinus invasion may develop, though this is less common than with other sellar masses 5

Endocrine Dysfunction

  • Endocrine disturbances are typically permanent and result from compression or invasion of the pituitary gland and hypothalamus 1
  • Growth retardation and delayed puberty are common presenting features in children due to disruption of the hypothalamic-pituitary axis 1
  • Hypopituitarism develops from mass effect on the pituitary gland within the sella turcica 5

Imaging Characteristics

MRI Findings

  • MRI using high-resolution pituitary protocols is the gold standard for evaluating craniopharyngiomas and their relationship to the sella turcica 5, 7
  • The neuroradiological diagnosis is based on three tumor components (cystic, solid, and calcified) in the characteristic sellar/parasellar location 1
  • Thin-section T1-weighted and T2-weighted sequences with pre- and post-contrast imaging define tumor extent and relationship to critical structures 7

CT Utility

  • CT is superior for detecting calcification, which is typical of pediatric adamantinomatous craniopharyngiomas 2
  • CT provides essential osseous detail for anatomy in the sphenoid sinus prior to transsphenoidal surgery 5
  • Thin-section acquisition with multiplanar reformatting aids intraoperative navigation and demonstrates sellar bony changes 5

Clinical Implications

Presentation Patterns

  • Headaches represent the most common neurological symptom at presentation 1
  • Visual disturbances occur from suprasellar extension compressing the optic chiasm 3, 1
  • Endocrine dysfunction including growth hormone deficiency, delayed puberty, and panhypopituitarism results from sellar and suprasellar involvement 1

Surgical Considerations

  • Transsphenoidal resection through the sella turcica is the mainstay of treatment for most craniopharyngiomas 7
  • Endoscopic endonasal approaches utilize the natural corridor through the sphenoid sinus to access the sella and suprasellar region 2
  • Prechiasmatic/preinfundibular lesions are effectively removed using an endonasal transtuberculum/transplanum approach, while subchiasmatic/transinfundibular tumors require a transellar approach 2

Critical Pitfalls

  • Do not delay surgical planning for resectable lesions, as visual recovery is unlikely after the first postoperative month 7
  • Avoid attributing all symptoms to the craniopharyngioma without considering the specific anatomic relationships and compression patterns 8
  • Do not overlook the need for lifelong endocrine surveillance, as hormonal deficiencies from sellar involvement are typically permanent 7, 1

References

Research

Craniopharyngioma.

Orphanet journal of rare diseases, 2007

Research

Infrasellar craniopharyngioma: case report.

Arquivos de neuro-psiquiatria, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nasopharyngeal craniopharyngioma. Case report and literature review.

The Annals of otology, rhinology, and laryngology, 1990

Guideline

Management of Sellar Masses in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Incidental Partially Empty Sella in a Patient with Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.